Good Treatment review of biologics (IL-1, IL-6) in systemic JIA (Stills) including complications of #MAS and lung diseas
Tweet Content
Good Treatment review of biologics (IL-1, IL-6) in systemic JIA (Stills) including complications of #MAS and lung disease; also info on horizon therapies like JAK inhibitors and IL-18 targeting and novel biomarkers (calgranulins, IL-18 and CXCL9) https://t.co/Cbd7bKdIbb https://t.co/d9tn9fmSAy
Links
Treatment of systemic juvenile idiopathic arthritis
https://go.nature.com/3MGmd4f
Show on Archive Page
On
Display in Search Results
On
PDQ
Off